Dhruv Patel

Dhruv Patel

Auto-generated profile, based on publicly available information

Dhruv Patel

ENT Department, Luton and Dunstable University Hospital, Bedfordshire Hospitals NHS Foundation Trust , LU4 0DZ, Luton

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2023 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Open access
VLVictor Yan Zhe Lu
Victor Yan Zhe Lu
VJVinosh Jegatheesan
Vinosh Jegatheesan
DPDhruv Patel
Dhruv Patel
PDPeter Domos
Peter Domos
Reverse shoulder arthroplasty (RSA) has become an increasingly popular treatment option for proximal humerus fractures in the elderly. There is however contradictory evidence on the impact of timing of RSA on patient outcomes. It remains unclear if poor results after initial nonsurgical or surgical management can be improved with delayed RSA. The aim of this systematic review and meta-analysis is to compare the outcomes of acute RSA and delayed RSA for the treatment of proximal humerus fractures in the elderly. A systematic search was performed on 4 databases for studies that compared acute RSA with RSA used after prior nonoperative or operative treatment. Studies with a mean cohort age of <65 years were excluded. Demographical data, clinical outcome scores, range of motion measurements, and postoperative complications were collected from the included studies. Sixteen studies were included for data analysis. Compared with delayed RSA cohorts, acute RSA cohorts had higher forward flexion (124.3° vs. 114.9°; P = .019), external rotation (24.7° vs. 20.2°; P = .041), and abduction (113.2° vs. 99.8°; P = .03). Compared with RSA after conservative management, acute RSA had greater external rotation (29.9° vs. 21.4°; P = .043). The acute RSA cohort had significantly higher American Shoulder and Elbow Surgeons (76.4 vs. 68.2; P = .025) and Constant-Murley scores (65.6 vs. 57.3; P = .002) compared with the delayed RSA cohort. Subgroup analyses showed significantly greater Constant-Murley (64.9 vs. 56.9; P = .020) and Simple Shoulder Test scores (8.8 vs. 6.8; P = .031) with acute RSA compared with RSA after conservative treatment. The American Shoulder and Elbow Surgeons score was higher in the acute RSA cohort compared with RSA after open reduction internal fixation (77.9 vs. 63.5; P = .008). The overall complication rate per 100 patient-years was 11.7 for the acute RSA cohort and 18.5 for the delayed RSA cohort (risk ratio: 0.55; P = .015). Based on the current evidence, acute RSA presents better clinical outcome measures and range of motion measurements, with decreased complication rates than RSA performed after prior nonoperative or operative treatment.

2 August 2023 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Open access
VJVinosh Jegatheesan
Vinosh Jegatheesan
DPDhruv Patel
Dhruv Patel
VLVictor Yan Zhe Lu
Victor Yan Zhe Lu
PDPeter Domos
Peter Domos
Latarjet has become an increasingly popular treatment option for recurrent anterior shoulder instability. With the reported complication rates for primary Latarjet surgery, there are concerns about the complications of Latarjet as a revision surgery. It remains unclear if poor results after previous surgical management can be improved with revision Latarjet as well as with primary Latarjet. The aim of this systematic review and meta-analysis is to compare the outcomes of primary Latarjet and revision Latarjet for the treatment of anterior shoulder instability. A systematic search was performed on three databases for studies that compared primary Latarjet with revision Latarjet used after failed arthroscopic stabilization or failed free bone block procedures. From the included studies demographical data, clinical outcome scores, range of motion measurements, and postoperative complications were obtained. A total of 11 studies were included for data analysis. Compared with the primary Latarjet cohort, revision Latarjet cohorts had a higher infection rate (1.2% vs 2.6%; RR: 0.46, p=0.039). The primary Latarjet group showed a greater return to sport (89.7% vs 80.5%; RR:1.12, p=0.41) and less subjective feeling of instability (12.6% vs 20.9%; RR: 0.60, p=0.085) compared to the revision Latarjet group, however, this was not statistically significant. There were no significant differences in complication rates, reoperation, recurrence and range of motion between primary Latarjet and revision Latarjet groups. Clinical outcome scores such as VAS and Rowe scores were not significantly different between the cohorts. Based on the current evidence, primary Latarjet presents reduced infection rates but similar clinical outcome measures, overall complication, and range of motion measurements than revision Latarjet performed after failed prior operative treatment.

8 January 2026 in FEMS Microbes
Verified
Journal Article
Open access
DPDhruv Patel
Dhruv Patel
JMJames Morris
James Morris
FSFrancesca Speck
Francesca Speck
MFMatthew Flynn
Matthew Flynn
Infectious mononucleosis is clinically difficult to distinguish from bacterial causes of tonsillitis/pharyngitis. First-line investigations include monospot testing, despite 63% sensitivity in certain cohorts. Therefore, national recommendations include repeating an initial negative monospot within five to seven days. A point-of-care clinical scoring tool could improve clinical outcomes, increase diagnostic accuracy and reduce unnecessary testing. We conducted a retrospective cohort study at Luton and Dunstable University Hospital including patients aged 15–24 presenting with sore throat, lymphadenopathy or fever between 01/01/2021 and 31/01/2024 who underwent monospot testing. Extracted data included demographics, observations, and laboratory results. Patients were randomly split into training (80%) and testing (20%) cohorts. Eleven parameters were used to develop four predictive models; classical multivariate logistic regression, machine-learning logistic regression with LIBLINEAR approximation, machine-learning decision tree classifier, and a simplified clinical risk-stratification model from machine-learning methods. Total of 278 presentations from 264 patients were included. The machine-learning decision tree classifier demonstrated superior performance, achieving 100% sensitivity, 98.0% specificity, and 98.2% diagnostic accuracy using only three parameters: lymphocyte count, neutrophil count, and alanine aminotransferase. The simplified clinical risk-stratification model demonstrated 83.3% sensitivity, 98.0% specificity, and overall 96.4% accuracy. All four models represent potential methods for developing clinical tools to predict monospot positivity. Our risk-stratification model showed significant promise as an easily memorisable, point-of-care clinical scoring tool. Using this, we propose an alternative diagnostic pathway with early counselling and de-escalation of antibiotics in high-risk cases, and reduced testing in low-risk cases; reducing population-level morbidity and epidemiological spread, whilst improving diagnostic accuracy and conserving resources.